Evolution of smoking prevalence in Spain and its 17 autonomous regions (1987-2020)
Copyright © 2023 Elsevier España, S.L.U. All rights reserved..
BACKGROUND AND OBJECTIVES: Continuous monitoring of smoking prevalence is essential to understand the evolution of the tobacco epidemic in a population. The objective of this study was to analyze the evolution of smoking prevalence in Spain and its 17 Autonomous Regions (ARs) in population ≥15 years during the period 1987-2020.
METHODS: Tobacco consumption data were derived from the National Health Survey of Spain and the European Health Survey in Spain. A smoker was defined as a person who smoked at the time of the survey. The trend in prevalences by sex in Spain and its ARs was analyzed by applying joinpoint models. Age-standardized prevalences were calculated for Spain by applying the direct method.
RESULTS: In Spain, the prevalence of consumption decreased 29 percentage points in men and 4.5 in women between 1987-2020. In men, the smoking prevalence decreased in all the ARs and the absolute change varied between -19.5% in the Balearic Islands and -33.9% in Andalusia. In women, the evolution of smoking prevalence differed between ARs. The absolute change varied between -15.4% in Basque Country and 0.5% in Andalusia.
CONCLUSIONS: The number of men and women smokers has decreased in Spain between 1987-2020. Different patterns of evolution of the prevalence of consumption are observed among the ARs, especially among women. This reinforces the need for policies adapted to more local contexts and that take into account the gender perspective.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Medicina clinica - (2024) vom: 05. Jan. |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Evolución de la prevalencia de consumo de tabaco en España y sus 17 comunidades autónomas (1987-2020) |
|---|
| Beteiligte Personen: |
Rey-Brandariz, Julia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adult |
|---|
| Anmerkungen: |
Date Revised 06.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.medcli.2023.11.015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366750798 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366750798 | ||
| 003 | DE-627 | ||
| 005 | 20240108142824.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.medcli.2023.11.015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1251.xml |
| 035 | |a (DE-627)NLM366750798 | ||
| 035 | |a (NLM)38184463 | ||
| 035 | |a (PII)S0025-7753(23)00715-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rey-Brandariz, Julia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evolution of smoking prevalence in Spain and its 17 autonomous regions (1987-2020) |
| 246 | 3 | 3 | |a Evolución de la prevalencia de consumo de tabaco en España y sus 17 comunidades autónomas (1987-2020) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a BACKGROUND AND OBJECTIVES: Continuous monitoring of smoking prevalence is essential to understand the evolution of the tobacco epidemic in a population. The objective of this study was to analyze the evolution of smoking prevalence in Spain and its 17 Autonomous Regions (ARs) in population ≥15 years during the period 1987-2020 | ||
| 520 | |a METHODS: Tobacco consumption data were derived from the National Health Survey of Spain and the European Health Survey in Spain. A smoker was defined as a person who smoked at the time of the survey. The trend in prevalences by sex in Spain and its ARs was analyzed by applying joinpoint models. Age-standardized prevalences were calculated for Spain by applying the direct method | ||
| 520 | |a RESULTS: In Spain, the prevalence of consumption decreased 29 percentage points in men and 4.5 in women between 1987-2020. In men, the smoking prevalence decreased in all the ARs and the absolute change varied between -19.5% in the Balearic Islands and -33.9% in Andalusia. In women, the evolution of smoking prevalence differed between ARs. The absolute change varied between -15.4% in Basque Country and 0.5% in Andalusia | ||
| 520 | |a CONCLUSIONS: The number of men and women smokers has decreased in Spain between 1987-2020. Different patterns of evolution of the prevalence of consumption are observed among the ARs, especially among women. This reinforces the need for policies adapted to more local contexts and that take into account the gender perspective | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adult | |
| 650 | 4 | |a Adulto | |
| 650 | 4 | |a Comunidades autónomas | |
| 650 | 4 | |a Encuestas epidemiológicas | |
| 650 | 4 | |a Epidemiological surveys | |
| 650 | 4 | |a España | |
| 650 | 4 | |a Prevalence | |
| 650 | 4 | |a Prevalencia | |
| 650 | 4 | |a Region | |
| 650 | 4 | |a Spain | |
| 650 | 4 | |a Tabaco | |
| 650 | 4 | |a Tobacco | |
| 700 | 1 | |a Ruano-Ravina, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Santiago-Pérez, María Isolina |e verfasserin |4 aut | |
| 700 | 1 | |a Varela-Lema, Leonor |e verfasserin |4 aut | |
| 700 | 1 | |a Guerra-Tort, Carla |e verfasserin |4 aut | |
| 700 | 1 | |a Montes, Agustín |e verfasserin |4 aut | |
| 700 | 1 | |a Piñeiro, María |e verfasserin |4 aut | |
| 700 | 1 | |a Rábade, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez-Ríos, Mónica |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina clinica |d 1948 |g (2024) vom: 05. Jan. |w (DE-627)NLM000359017 |x 1578-8989 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:05 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medcli.2023.11.015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 05 |c 01 | ||